| 764358 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
239 Efficacy and toxicity of single agent immune checkpoint inhibitors among adults with cancer aged ≥80 years: a multicenter international cohort study |
2021-11-01 |
10.1136/jitc-2021-sitc2021.239 |
Nebhan Caroline, Cortellini Alessio, Ma Weijie, Ganta Teja, Song Haocan, Ye Fei, Irlmeier Rebecca, Debnath Neha, Saeed Anwaar, Radford Maluki, Alahmadi Asrar, Diamond Akiva, Hoimes Christopher, Ramaiya Nikhil, Presley Carolyn, Owen Dwight, Alaiwi Sarah Abou, Nassar Amin, Ricciuti Biagio, Lamberti Giuseppe, Bersanelli Melissa, Casartelli Chiara, Buti Sebastiano, Marchetti Paolo, Giusti Raffaele, Filetti Marco, Vanella Vito, Mallardo Domenico, Macherla Shravanti, Sussman Tamara, Botticelli Andrea, Galetta Domenico, Catino Annamaria, Pizzutilo Pamela, Genova Carlo, Bello Maria Giovanna Dal, Kalofonou Foteini, Daniels Ella, Ascierto Paolo, Pinato David, Choueiri Toni, Johnson Douglas, Marron Thomas, Wang Yinghong, Naqash Abdul Rafeh |
| 764357 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
227 A computational semi-mechanistic pharmacology model of ATG101, a PD-L1/4–1BB bispecific antibody for treatment of solid tumors and NHL |
2021-11-01 |
10.1136/jitc-2021-sitc2021.227 |
Flowers David, Presler Marc, Subramanian Kas, Yuraszeck Theresa, Yuwen Hui, Hou Bing, Hoenemann Dirk |
| 764356 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
694 Possible immune-modulation of CDK4/6 inhibitors and clinical trial development in betel-nuts related head and neck squamous cell carcinoma in Taiwan |
2021-11-01 |
10.1136/jitc-2021-sitc2021.694 |
Chen Jo-Pai, Chang Jui-Ying, Kao Hsiang-Fong, Hong Ruey-Long |
| 764355 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
11 Molecular characterization of naturally occurring colorectal and breast cancer in non-human primates to model human immunotherapeutic agents |
2021-11-01 |
10.1136/jitc-2021-sitc2021.011 |
Deycmar Simon, Johnson Brendan, Ryan Declan, Sills William, Caudell David, Dugan Greg, Sai Kiran Solingapuram, Hettich Michael, Gomes Bruno, Ceppi Maurizio, Cline Mark |
| 764354 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
424 A phase 1b/2 randomized study of AVB-S6–500 in combination with cabozantinib versus cabozantinib alone in patients with advanced clear cell renal cell carcinoma who have received front-line treatment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.424 |
Beckermann Kathryn, Vogelzang Nicholas, Shifeng Mao, Ornstein Moshe, Shah Neil, Hammers Hans, Campbell Matthew, Gao Xin, McDermott David, Anderson Randy, Esquibel Vanessa, Pennella Eduardo, Rangwala Reshma, Jonasch Eric |
| 764353 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
25 Potential role of serum proteome in predicting immune-related adverse events from immunotherapy in non-small cell lung cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.025 |
Kim Leeseul, Chae Young Kwang, Lee Dong-Uk |
| 764352 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
22 The potential of serum autoantibodies against type III collagen in cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.022 |
Jensen Christina, Thorlacius-Ussing Jeppe, Drobinski Patryk, Karsdal Morten, Bay-Jensen Anne-Christine, Willumsen Nicholas |
| 764351 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
20 Tumor-informed liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.020 |
Abbott Charles, Bedi Nikita, Wang Jing, Northcott Josette, Pyke Rachel, Li Robin, McDaniel Lee, Levy Eric, Mansour Mena, Colevas Dimitrios, Lyle John, Sunwoo John, Boyle Sean, Chen Richard |
| 764350 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
16 Tumor growth inhibition mediated by a single dose of intratumoral TransCon™ TLR7/8 agonist was associated with activated circulating T and B cells and sustained low levels of systemic cytokines |
2021-11-01 |
10.1136/jitc-2021-sitc2021.016 |
Mirza Amer, Zuniga Luis, Uppal Karan, Bang Kathy, Hong Enping, Sabharwal Simran, Lee Yuchi, Martinez Salomon, Rosen David, Punnonen Juha |
| 764349 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
14 Claudin-6 affects the cell cycle and p53 signaling in Gastric cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.014 |
Dwivedi Sanyog |
